BUG PHARMA

USPTO USPTO 2002 CANCELLED - SECTION 8

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The US trademark BUG PHARMA was filed as Word mark on 08/12/2002 at the U.S. Patent and Trademark Office.
It was registered as a trademark on 03/15/2005. The current status of the mark is "CANCELLED - SECTION 8".

Trademark Details

Trademark form Word mark
File reference 78153337
Register number 2932682
Application date August 12, 2002
Publication date July 27, 2004
Entry date March 15, 2005

Trademark owner

351 Royal Parade
VIC 3052 Parkville
AU

Trademark representatives

goods and services

1 Chemicals and chemical substances containing arthropodic substances for use in manufacturing pharmaceutical preparations these being utilized in scientific industries
5 PHARMACEUTICAL PREPARATIONS CONTAINING ARTHROPODIC DERIVED SUBSTANCES FOR THE TREATMENT OF HUMAN AILMENTS, MEDICAL DISORDERS AND DISEASES, NAMELY-- INFECTIOUS DISEASES CAUSED BY BACTERIA, FUNGI, VIRUSES, HELMINTHS, PROTOZOA AND PARASITES, INCLUDING AIDS AND HEPATITIS C; CANCER INCLUDING CANCERS OF THE BREAST, PROSTATE, LUNG, COLON, SKIN, BRAIN, BLOOD AND ERYTHROPOIETIC CELLS (LEUKEMIAS, MYELOMAS); HEART DISEASE; CARDIOVASCULAR DISEASE INCLUDING STROKE, HYPERTENSION AND ATHEROSCLEROSIS; NEUROSES AND PSYCHOSES - ANXIETY, SCHIZOPHRENIA, DEPRESSION, AND BIPOLAR DISORDER; OBESITY; DIABETES (TYPE 1 AND TYPE 2); ASTHMA; HYPERTENSION; HYPERCHOLESTEROLEMIA; PAIN (CHRONIC AND ACUTE); INFLAMMATION INCLUDING ARTHRITIS, OSTEOARTHRITIS; AUTOIMMUNE DISEASES; PSORIASIS, ECZEMA; CYSTIC FIBROSIS; GASTRO-INTESTINAL DISEASE, INCLUDING ULCERS, HELICOBACTER PYLORI INFECTIONS; SEXUAL DYSFUNCTION; OPHTHALMIC DISORDERS INCLUDING GLAUCOMA; IMMUNE SUPPRESSION FOLLOWING TRANSPLANTATION; REPRODUCTIVE DISORDERS; CONTRACEPTION AND CONTROL OF REPRODUCTION; CYSTIC FIBROSIS AND GENETIC DISORDERS; AND DEGENERATIVE DISEASES INCLUDING ALZHEIMER'S DEMENTIA
42 Pharmaceutical drug development services for drugs containing arthropodic derived substances
44 PHARMACEUTICAL CONSULTATION NAMELY IN THE FIELD OF DRUGS CONTAINING ARTHROPODIC DERIVED SUBSTANCES

ID: 1378153337